Cargando…
Chondroprotective effects of CDK4/6 inhibition via enhanced ubiquitin-dependent degradation of JUN in synovial fibroblasts
OBJECTIVE: Targeting synovial fibroblasts (SF) using a cyclin-dependent kinase (CDK) 4/6 inhibitor (CDKI) could be a potent therapy for RA via inhibition of proliferation and MMP-3 production. This study was designed to elucidate the mechanism of chondroprotective effects on SFs by CDK 4/6 inhibitio...
Autores principales: | Hosoya, Tadashi, Saito, Tetsuya, Baba, Hiroyuki, Tanaka, Nao, Noda, Seiji, Komiya, Youji, Tagawa, Yasuhiro, Yamamoto, Akio, Mizoguchi, Fumitaka, Kawahata, Kimito, Miyasaka, Nobuyuki, Kohsaka, Hitoshi, Yasuda, Shinsuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348617/ https://www.ncbi.nlm.nih.gov/pubmed/34849618 http://dx.doi.org/10.1093/rheumatology/keab874 |
Ejemplares similares
-
CD34(+)THY1(+) synovial fibroblast subset in arthritic joints has high osteoblastic and chondrogenic potentials in vitro
por: Noda, Seiji, et al.
Publicado: (2022) -
Correction: CD34(+)THY1(+) synovial fibroblast subset in arthritic joints has high osteoblastic and chondrogenic potentials in vitro
por: Noda, Seiji, et al.
Publicado: (2022) -
Interleukin-23 as a therapeutic target for inflammatory myopathy
por: Umezawa, Natsuka, et al.
Publicado: (2018) -
Targeting necroptosis in muscle fibers ameliorates inflammatory myopathies
por: Kamiya, Mari, et al.
Publicado: (2022) -
A new in vitro model of polymyositis reveals CD8(+) T cell invasion into muscle cells and its cytotoxic role
por: Kamiya, Mari, et al.
Publicado: (2020)